Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27249003)

Published in Int J Environ Res Public Health on May 30, 2016

Authors

Lei Hu1,2, Shu-Hui Chen3, Qiao-Li Lv4,5, Bao Sun6,7, Qiang Qu8, Chong-Zhen Qin9, Lan Fan10,11, Ying Guo12,13, Lin Cheng14, Hong-Hao Zhou15,16

Author Affiliations

1: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. hu773589905@163.com.
2: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China. hu773589905@163.com.
3: Department of Oncology, Changsha Central Hospital, Changsha 410006, China. chenshuhui2008@126.com.
4: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. lvqiaoli2008@126.com.
5: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China. lvqiaoli2008@126.com.
6: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. scy_csu2016@163.com.
7: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China. scy_csu2016@163.com.
8: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China. quqiang1983@sina.com.
9: Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Central South University, Zhengzhou 450052, China. qcz0378@126.com.
10: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. fanlan_038038@163.com.
11: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China. fanlan_038038@163.com.
12: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. guoying881212@csu.edu.cn.
13: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China. guoying881212@csu.edu.cn.
14: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China. kjade.cheng@hotmail.com.
15: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. hhzhou2003@163.com.
16: Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, China. hhzhou2003@163.com.

Articles cited by this

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74

Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52

Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet (2007) 11.62

Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet (2007) 9.88

The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell (2010) 8.66

The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet (2009) 6.99

Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82

The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet (2009) 5.65

A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res (2008) 2.43

Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun (2005) 2.34

Genetics of lung-cancer susceptibility. Lancet Oncol (2010) 2.24

Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics (2009) 1.71

Long non-coding RNA in cancer. Int J Mol Sci (2013) 1.52

LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol (2012) 1.40

Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev (2010) 1.38

An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol (2005) 1.33

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. Lung Cancer (2008) 1.27

Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer (2012) 1.18

GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes. Carcinogenesis (2012) 1.16

The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep (2008) 1.09

Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer (2012) 1.07

POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. Prostate (2010) 1.06

Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clin Oncol (2005) 1.01

Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumour Biol (2016) 0.95

Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma. Cancer Chemother Pharmacol (2016) 0.93

Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Med Oncol (2011) 0.93

Elucidating the role of 8q24 in colorectal cancer. Nat Genet (2009) 0.93

Association of 8q24.21 loci with the risk of colorectal cancer: a systematic review and meta-analysis. J Gastroenterol Hepatol (2011) 0.90

Polymorphisms on 8q24 are associated with lung cancer risk and survival in Han Chinese. PLoS One (2012) 0.87

Genetic variant in 8q24 is associated with prognosis for gastric cancer in a Chinese population. J Gastroenterol Hepatol (2015) 0.85

Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy. Med Oncol (2016) 0.84

Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection. Int J Mol Sci (2014) 0.84

Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results. Medicine (Baltimore) (2015) 0.84

Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients. J Neurol Sci (2015) 0.80

Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer. FEBS Open Bio (2015) 0.78

Association analysis of colorectal cancer susceptibility variants with gastric cancer in a Chinese Han population. Genet Mol Res (2014) 0.78

Predictive potential role of GSTs gene polymorphisms in the treatment outcome of advanced non-small cell lung cancer patients. Int J Clin Exp Med (2015) 0.77

A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer. Oncotarget (2016) 0.77

Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity. Tumour Biol (2015) 0.77

Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2. Biochim Biophys Acta (2015) 0.77

Association of 8q23-24 region (8q23.3 loci and 8q24.21 loci) with susceptibility to colorectal cancer: a systematic and updated meta-analysis. Int J Clin Exp Med (2015) 0.76